Business Planning

ALBUQUERQUE, N.M. — NATO delegates toured Sandia National Laboratories during a three-day visit highlighting the labs’ programs that support extended deterrence to U.S. allies, as well as broader national security programs ranging from homeland security to preventing the proliferation of weapons of mass destruction.
| 2 min read

CEM Corporation, a competitor of Biotage (STO: BIOT), recently published a press release claiming to have won a “patent dispute” with Biotage. The so called “patent dispute” relates to Biotage’s filing of opposition against certain patents of CEM in Europe* (Germany, France, Italy and Great Britain) and Japan, because Biotage believes that the patents as originally granted give CEM a broader protection than CEM is entitled to.
| 2 min read

The Department of Biological Sciences (DBS) of the Faculty of Science at NUS has received a generous gift of S$1 million from Singapore Exchange Catalist-listed developer SingHaiyi Group Limited and its parent company, privately held Haiyi Holdings Pte Ltd. The donation will attract the prevailing matching grant from the Singapore Government.
| 2 min read

Lawrence Livermore National Security (LLNS) has released a request for information (RFI) from parties interested in potential leases at the planned Livermore Valley Open Campus (LVOC).
| 1 min read

Researchers at McMaster University have a unique new facility that enables a fresh approach to developing materials for real-world problems such as hospital doorknobs that can repel bacteria, bandages that can heal wounds, home test kits for cholesterol and contact lenses that rarely need changing.
| 2 min read

The San Diego Supercomputer Center (SDSC) at the University of California, San Diego will host its first annual research review for current and prospective industrial partners and affiliates as part of a broader strategy to foster increased collaborations that may benefit from the center’s extensive research capabilities.
| 2 min read

Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, and Life Technologies Corporation (NASDAQ: LIFE), a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year end 2012).
| 4 min read








